IE902162L - Novel cyclodextrin inclusion complexes - Google Patents

Novel cyclodextrin inclusion complexes

Info

Publication number
IE902162L
IE902162L IE902162A IE216290A IE902162L IE 902162 L IE902162 L IE 902162L IE 902162 A IE902162 A IE 902162A IE 216290 A IE216290 A IE 216290A IE 902162 L IE902162 L IE 902162L
Authority
IE
Ireland
Prior art keywords
cyclodextrin inclusion
inclusion complexes
novel cyclodextrin
complex
preparation
Prior art date
Application number
IE902162A
Other versions
IE902162A1 (en
Original Assignee
Dorran Photonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dorran Photonics Inc filed Critical Dorran Photonics Inc
Publication of IE902162L publication Critical patent/IE902162L/en
Publication of IE902162A1 publication Critical patent/IE902162A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

An inclusion complex of 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]amino]-2-hydroxypropoxy]-benzon itrile having formula (I) with one or more cyclodextrins, which is useful for the treatment of cardiac arrhythmias, process for the preparation of said complex as well as the use of said complex for the preparation of medicaments with action against cardiac arrhythmias. [WO9015792A1]
IE216290A 1989-06-20 1990-06-15 Novel cyclodextrin inclusion complexes IE902162A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902235A SE8902235D0 (en) 1989-06-20 1989-06-20 NOVEL CYCLODEXTRIN INCLUSION COMPLEXES

Publications (2)

Publication Number Publication Date
IE902162L true IE902162L (en) 1990-12-20
IE902162A1 IE902162A1 (en) 1991-01-02

Family

ID=20376340

Family Applications (1)

Application Number Title Priority Date Filing Date
IE216290A IE902162A1 (en) 1989-06-20 1990-06-15 Novel cyclodextrin inclusion complexes

Country Status (15)

Country Link
EP (1) EP0478677A1 (en)
JP (1) JPH04506212A (en)
KR (1) KR920702674A (en)
AU (1) AU641670B2 (en)
CA (1) CA2058996A1 (en)
DD (1) DD297404A5 (en)
FI (1) FI915935A0 (en)
GR (1) GR1000747B (en)
HU (1) HUT59085A (en)
IE (1) IE902162A1 (en)
LT (1) LTIP1725A (en)
LV (1) LV10249A (en)
PT (1) PT94415A (en)
SE (1) SE8902235D0 (en)
WO (1) WO1990015792A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
DE4227569C1 (en) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Enzymatic determn. of inorganic phosphate - using combination of di:saccharide phosphorylase, phosphatase or maltose synthase, and glucose oxido-reductase
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
TWI373473B (en) * 2005-09-02 2012-10-01 Otsuka Pharma Co Ltd Anticancer agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457876A (en) * 1972-12-15 1976-12-08 Ici Ltd Alkanolamine derivatives device for use in
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives
HU177081B (en) * 1978-12-12 1981-07-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing the occlusion complex of allicin with cyclodextrin
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
JPS5718602A (en) * 1980-05-28 1982-01-30 Hokko Chem Ind Co Ltd Herbicide
DE3372705D1 (en) * 1982-04-30 1987-09-03 Takeda Chemical Industries Ltd Pharmaceutical composition and its use
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE
SE8902237D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL STEREOISOMERS

Also Published As

Publication number Publication date
LV10249A (en) 1994-10-20
KR920702674A (en) 1992-10-06
FI915935A0 (en) 1991-12-17
HU905542D0 (en) 1992-03-30
PT94415A (en) 1991-02-08
WO1990015792A1 (en) 1990-12-27
HUT59085A (en) 1992-04-28
LTIP1725A (en) 1995-07-25
IE902162A1 (en) 1991-01-02
EP0478677A1 (en) 1992-04-08
AU641670B2 (en) 1993-09-30
DD297404A5 (en) 1992-01-09
GR1000747B (en) 1992-12-30
JPH04506212A (en) 1992-10-29
GR900100458A (en) 1991-11-15
SE8902235D0 (en) 1989-06-20
CA2058996A1 (en) 1990-12-21
AU5937490A (en) 1991-01-08

Similar Documents

Publication Publication Date Title
WO2001028992A3 (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
WO2001037989A3 (en) Oligomerisation catalyst, a method for production and the use thereof
WO1996015784A3 (en) 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance
EP0965323A3 (en) Agents and compositions thereof for the hair treatment containing depolymerized fucane sulphates
MXPA02006249A (en) New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias.
EP0333243A3 (en) Sulphated k5 antigen and sulphated k5 antigen fragments
IE902162L (en) Novel cyclodextrin inclusion complexes
CA2015235A1 (en) Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
BR0206791A (en) Compound, pharmaceutical formulation, use of a compound, method of prophylaxis or treatment of an arrhythmia, and process for the preparation of a compound
EP0322815A3 (en) Propoxybenzene derivatives and process for preparing the same
EP0711773A4 (en)
CA2048242A1 (en) 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors
AU5067696A (en) Antiarrhythmic and cardioprotective substituted indenoylguanidines
EP0739905A4 (en) Polymerization catalyst and process for producing styrene polymer therewith
YU120590A (en) NEW POLYSTYRENESULPHONATE
EP0378146A3 (en) Polyamine derivatives as antineoplastic agents
BR0011660A (en) Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia and, process for the preparation of a compound
CA2292017A1 (en) Substituted cycloheptenes, their preparation and use
BR0011673A (en) Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia and, process for preparing a compound
BR0011675A (en) Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia, and process for preparing a compound
BR0011667A (en) Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia, and process of preparing a compound
WO1995028956A3 (en) Antifibrillatory agent in myocardial reperfusion
TH24865B (en) Process for producing epoxides from olefins
TH24865A (en) Process for producing epoxides from olefins